fluorescein-5-isothiocyanate has been researched along with Histiocytosis, Langerhans-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haga, H; Hirata, M; Kataoka, TR; Moriyoshi, K; Nabeshima, Y; Ono, K; Saito, N; Takei, Y; Takeuchi, Y; Ueshima, C | 1 |
1 other study(ies) available for fluorescein-5-isothiocyanate and Histiocytosis, Langerhans-Cell
| Article | Year |
|---|---|
Neonatal Fc receptor induces intravenous immunoglobulin growth suppression in Langerhans cell histiocytosis.
Topics: Adolescent; Adult; Albumins; Cell Line; Child; Child, Preschool; Female; Fluorescein-5-isothiocyanate; Histiocytosis, Langerhans-Cell; Histocompatibility Antigens Class I; Humans; Immunoglobulins, Intravenous; Infant; Infant, Newborn; Male; Receptors, Fc; Serum Albumin | 2021 |